Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Marcus358on Apr 12, 2021 8:44am
67 Views
Post# 32976160

RE:Clarus Analyst has talked........HOLD

RE:Clarus Analyst has talked........HOLD
Marcus358 wrote: Clarus analyst has downgraded this stock from Buy to Hold...from a target price of $4 to 1.25 a 68% decreased in target price......

So my friendly advice to everyone.

for the Buyer.....HOLD your Buying until we see a clear direction of this company. I don't want you to be a BIG Time bagholder if history repeat itself like what happen last week and the past 3 years.

for the SELLER ....Hold if  your at a lost....wait if Tripp has something in his pocket to drive the price up or sell to minimized your lost in case this will continue diving which is what we are seeing unless something big come out....that will serve as a catalyst for the price to go up.

Wait and see is the game here now. many are bagholder and want to get out. any price up is an opportunity to get out. so be careful folks. lets wait until the dust settle...it is easy to get in but hard to get out here.




<< Previous
Bullboard Posts
Next >>